Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sanfilippo

Showing results (151-160 of 273) with videos related to

Pageof 28
Sort By:
Journal of Chemotherapy (Florence, Italy)|June 6, 2017
Optimizing adherence to advice from antimicrobial stewardship audit and feedback roundsMatthew D M Rawlins, Frank M Sanfilippo, Paul R Ingram, et al.
Clinical Epidemiology|September 21, 2018
Operationalization and validation of a novel method to calculate adherence to polypharmacy with refill data from the Australian pharmaceutical benefits scheme (PBS) databaseIsabelle Arnet, Melanie Greenland, Matthew W Knuiman, et al.
Cornea|September 18, 2010
Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitisMelissa E Sanders, Quincy C Moore, Erin W Norcross, et al.
Infectious Diseases Now|July 4, 2024
Supply of nirmatrelvir/ritonavir and molnupiravir for patients with COVID-19 in the first eight months since listing on the Australian Pharmaceutical Benefits Scheme: A retrospective observational studyDerrick Lopez, Douglas Pritchard, Frank M Sanfilippo, et al.
Research and Practice in Thrombosis and Haemostasis|January 14, 2022
Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myelomaKristen M Sanfilippo, Kenneth R Carson, Tzu-Fei Wang, et al.
Paediatric and Perinatal Epidemiology|September 6, 2025
Changes in the Dispensing of Antibiotics to Australian Children Between 2013 and 2023: Are We Heading in the Right Direction?Erin Kelty, Ella Tairy, Scott Sims, et al.
Circulation. Cardiovascular Quality and Outcomes|August 25, 2011
Age- and sex-specific trends in the incidence of hospitalized acute coronary syndromes in Western AustraliaLee J Nedkoff, Tom G Briffa, David B Preen, et al.
Heart (British Cardiac Society)|June 27, 2025
Single high-sensitivity troponin levels to assess patients with potential acute coronary syndromes: 1-year outcomesCara Barnes, Frank M Sanfilippo, Daniel Michael Fatovich, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 11, 2019
Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple MyelomaSu-Hsin Chang, Jason Gumbel, Suhong Luo, et al.
Journal of Clinical Medicine|January 11, 2024
Primary Care Clinicians' Prescribing Patterns of Reduced-Dose Direct Oral Anticoagulants for Extended-Phase Venous Thromboembolism TreatmentDanielle Groat, Karlyn A Martin, Rachel P Rosovsky, et al.
Pageof 28

Showing results (151-160 of 273) with videos related to

Sort By:
Pageof 28
Journal of Chemotherapy (Florence, Italy)|June 6, 2017
Optimizing adherence to advice from antimicrobial stewardship audit and feedback roundsMatthew D M Rawlins, Frank M Sanfilippo, Paul R Ingram, et al.
Clinical Epidemiology|September 21, 2018
Operationalization and validation of a novel method to calculate adherence to polypharmacy with refill data from the Australian pharmaceutical benefits scheme (PBS) databaseIsabelle Arnet, Melanie Greenland, Matthew W Knuiman, et al.
Cornea|September 18, 2010
Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitisMelissa E Sanders, Quincy C Moore, Erin W Norcross, et al.
Infectious Diseases Now|July 4, 2024
Supply of nirmatrelvir/ritonavir and molnupiravir for patients with COVID-19 in the first eight months since listing on the Australian Pharmaceutical Benefits Scheme: A retrospective observational studyDerrick Lopez, Douglas Pritchard, Frank M Sanfilippo, et al.
Research and Practice in Thrombosis and Haemostasis|January 14, 2022
Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myelomaKristen M Sanfilippo, Kenneth R Carson, Tzu-Fei Wang, et al.
Paediatric and Perinatal Epidemiology|September 6, 2025
Changes in the Dispensing of Antibiotics to Australian Children Between 2013 and 2023: Are We Heading in the Right Direction?Erin Kelty, Ella Tairy, Scott Sims, et al.
Circulation. Cardiovascular Quality and Outcomes|August 25, 2011
Age- and sex-specific trends in the incidence of hospitalized acute coronary syndromes in Western AustraliaLee J Nedkoff, Tom G Briffa, David B Preen, et al.
Heart (British Cardiac Society)|June 27, 2025
Single high-sensitivity troponin levels to assess patients with potential acute coronary syndromes: 1-year outcomesCara Barnes, Frank M Sanfilippo, Daniel Michael Fatovich, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 11, 2019
Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple MyelomaSu-Hsin Chang, Jason Gumbel, Suhong Luo, et al.
Journal of Clinical Medicine|January 11, 2024
Primary Care Clinicians' Prescribing Patterns of Reduced-Dose Direct Oral Anticoagulants for Extended-Phase Venous Thromboembolism TreatmentDanielle Groat, Karlyn A Martin, Rachel P Rosovsky, et al.
Pageof 28